Coastal Investment Advisors Inc. grew its stake in UnitedHealth Group Inc (NYSE:UNH) by 30.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,309 shares of the healthcare conglomerate’s stock after buying an additional 1,012 shares during the period. Coastal Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $1,343,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. JJJ Advisors Inc. boosted its holdings in shares of UnitedHealth Group by 1,820.0% in the 3rd quarter. JJJ Advisors Inc. now owns 96 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 91 shares in the last quarter. Old North State Trust LLC purchased a new stake in UnitedHealth Group in the 3rd quarter valued at $39,000. Exchange Traded Concepts LLC raised its position in UnitedHealth Group by 140.0% in the 2nd quarter. Exchange Traded Concepts LLC now owns 132 shares of the healthcare conglomerate’s stock valued at $39,000 after purchasing an additional 77 shares during the last quarter. Clean Yield Group raised its position in UnitedHealth Group by 38.5% in the 3rd quarter. Clean Yield Group now owns 144 shares of the healthcare conglomerate’s stock valued at $45,000 after purchasing an additional 40 shares during the last quarter. Finally, Modus Advisors LLC purchased a new stake in UnitedHealth Group in the 2nd quarter valued at $62,000. Institutional investors and hedge funds own 86.39% of the company’s stock.

In related news, EVP Marianne D. Short sold 10,336 shares of the firm’s stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $312.34, for a total transaction of $3,228,346.24. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction dated Thursday, August 13th. The shares were sold at an average price of $320.59, for a total value of $4,808,850.00. Following the transaction, the director now directly owns 159,215 shares of the company’s stock, valued at approximately $51,042,736.85. The disclosure for this sale can be found here. Insiders have sold 37,336 shares of company stock valued at $11,893,276 in the last ninety days. Company insiders own 0.80% of the company’s stock.

Several equities research analysts have recently commented on UNH shares. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $293.00 to $312.00 and gave the stock a “buy” rating in a research note on Thursday, July 16th. SVB Leerink boosted their price target on UnitedHealth Group from $370.00 to $373.00 and gave the company an “outperform” rating in a report on Thursday, October 15th. Jefferies Financial Group increased their price target on UnitedHealth Group from $310.00 to $335.00 and gave the company a “hold” rating in a report on Thursday, October 15th. Barclays upped their price objective on shares of UnitedHealth Group from $322.00 to $365.00 and gave the company an “overweight” rating in a research report on Tuesday, October 13th. Finally, Stephens increased their price target on shares of UnitedHealth Group from $325.00 to $335.00 and gave the stock an “overweight” rating in a research report on Thursday, July 16th. Five equities research analysts have rated the stock with a hold rating, twenty have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $346.68.

Shares of NYSE:UNH traded up $4.87 on Friday, hitting $330.60. The company’s stock had a trading volume of 2,349,525 shares, compared to its average volume of 2,721,790. UnitedHealth Group Inc has a 12 month low of $187.72 and a 12 month high of $335.65. The company has a market capitalization of $314.18 billion, a price-to-earnings ratio of 18.99, a price-to-earnings-growth ratio of 1.53 and a beta of 0.68. The stock’s 50-day moving average is $313.06 and its two-hundred day moving average is $300.72. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.84 and a current ratio of 0.82.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.98 by $0.53. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The business had revenue of $65.12 billion during the quarter, compared to analysts’ expectations of $63.97 billion. During the same quarter last year, the business posted $3.88 earnings per share. The company’s quarterly revenue was up 7.9% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Inc will post 16.78 earnings per share for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: What are retained earnings?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.